Let’s start up with the current stock price of Onconova Therapeutics Inc. (ONTX), which is $0.59 to be very precise. The Stock rose vividly during the last session to $0.5466 after opening rate of $0.5155 while the lowest price it went was recorded $0.5115 before closing at $0.53.
Recently in News on May 10, 2021, Onconova Therapeutics to Provide Corporate Update and Announce First Quarter 2021 Financial Results on May 17, 2021. Company to host conference call and webcast at 4:30 p.m. Eastern Time on Monday, May 17. You can read further details here
Onconova Therapeutics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.9300 on 02/18/21, with the lowest value was $0.4350 for the same time period, recorded on 01/04/21.
Onconova Therapeutics Inc. (ONTX) full year performance was 46.11%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Onconova Therapeutics Inc. shares are logging -69.41% during the 52-week period from high price, and 210.52% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.19 and $1.93.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 5072833 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Onconova Therapeutics Inc. (ONTX) recorded performance in the market was 12.92%, having the revenues showcasing -54.66% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 118.90M, as it employees total of 11 workers.
Specialists analysis on Onconova Therapeutics Inc. (ONTX)
During the last month, 0 analysts gave the Onconova Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.8661, with a change in the price was noted +0.2341. In a similar fashion, Onconova Therapeutics Inc. posted a movement of +64.33% for the period of last 100 days, recording 39,198,027 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ONTX is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Trends and Technical analysis: Onconova Therapeutics Inc. (ONTX)
Raw Stochastic average of Onconova Therapeutics Inc. in the period of last 50 days is set at 13.49%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 34.38%. In the last 20 days, the company’s Stochastic %K was 17.08% and its Stochastic %D was recorded 12.01%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 12.92%. Additionally, trading for the stock in the period of the last six months notably improved by 94.67%, alongside a boost of 46.11% for the period of the last 12 months. The shares increased approximately by -11.57% in the 7-day charts and went up by -16.52% in the period of the last 30 days. Common stock shares were lifted by -54.66% during last recorded quarter.